Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance

The goal of this clinical study is to gain further insights into the treatment of patients with Low Anterior Resection Syndrome (LARS) symptoms after rectal resection. The main question is: Can LARS symptoms and quality of life be improved by implementing an intensified follow-up program? Researchers will compare the results of the intervention group with the results of a control group in which patients do not receive an intensified follow-up program to determine whether the intervention works. Participants will undergo an intensified follow-up program which consists of several follow-up visit

Trial Details

NCT ID
NCT06936774
Phase
PHASE3
Sponsor
University Hospital, Basel, Switzerland
Status
RECRUITING
Cancer Type
Colon Cancer Colorectal Cancer
Interventions
  • Intensified follow-up program
Locations (sample)
  • Basel, Switzerland|47.55839,7.57327
  • Bern, Switzerland|46.94809,7.44744
  • Bern, Switzerland|46.94809,7.44744
  • Lucerne, Switzerland|47.05048,8.30635
  • Winterthur, Switzerland|47.50564,8.72413

Key Eligibility Criteria

  • patients older than 18 years
  • patients with rectal cancer in the middle and lower third of the rectum in stages I to IV who underwent LAR with TME and protective ileostomy
  • able to give informed consent as documented by signature

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colon Cancer Colorectal Cancer Trials on Trialify →